MannKind | MNKD - 부채에 대한이자 비용





부채에 대한이자 비용 변화 날짜
Adma Biologics USD 1.63M 54K 2025-12
BioCryst Pharmaceuticals USD 14.14M 5.53M 2025-12
Eli Lilly USD 114.7M 134.3M 2025-09
Halozyme Therapeutics USD 4.91M 615K 2025-12
Insmed USD 20.6M 217K 2025-12
Karyopharm Therapeutics USD 11.38M 2.43M 2024-09
MacroGenics USD 3.34M 2.54M 2025-09
MannKind USD 13.87M 6.54M 2025-12
Merck USD 412M 85M 2025-12
Minerva Neurosciences USD 2.31M 60K 2024-06
Novavax USD 5.82M 342K 2025-12
Pfizer USD 711M 59M 2025-12
Sanofi EUR -25M 252M 2025-12
Xencor USD 7.35M 311K 2025-12